Key Takeaways
- Measure 110 decriminalized personal possession of small quantities of drugs in Oregon and redirected cannabis tax revenue to treatment services.
- Funding has expanded peer support, harm reduction, and low-barrier access to care, but utilization of the citation-to-treatment pathway has been far below projections.
- Overdose deaths in Oregon increased significantly after Measure 110's implementation, though causal attribution is debated among researchers.
- Legislative amendments in 2024 recriminalized public drug use and strengthened accountability mechanisms within the treatment referral system.
- Regardless of policy debates, evidence-based clinical treatment remains the most effective path to sustained recovery from addiction.
What Measure 110 Changed in Oregon
Ballot Measure 110, approved by Oregon voters with 58% support in November 2020 and implemented in February 2021, made Oregon the first U.S. state to decriminalize personal possession of all drugs. Under the new framework, possession of small quantities of controlled substances, including heroin, methamphetamine, cocaine, and fentanyl, was reclassified from a criminal misdemeanor to a Class E violation, equivalent to a traffic ticket carrying a maximum $100 fine. The fine could be waived if the individual called a treatment hotline for a health assessment.
The second major component of Measure 110 was financial. The law redirected a significant portion of Oregon's cannabis tax revenue, approximately $300 million over the first biennium, to the Drug Treatment and Recovery Services Fund. This fund was distributed to behavioral health resource networks (BHRNs) in every Oregon county to expand treatment, harm reduction, peer support, and housing services.
Proponents argued that criminalization had failed to reduce drug use, disproportionately harmed communities of color, and created barriers to seeking treatment. The measure's architects envisioned a health-centered approach that would redirect individuals away from the criminal justice system and toward voluntary treatment and recovery support services.
Measure 110 did not legalize drug use in Oregon. It reclassified personal possession from a criminal offense to a civil violation while directing funding toward treatment expansion.
The Treatment Funding Expansion
The influx of Measure 110 funding represented the largest single investment in addiction treatment infrastructure in Oregon's history. Behavioral health resource networks received grants to hire peer support specialists, open sobering centers and drop-in facilities, expand medication-assisted treatment, and provide housing support for individuals in recovery. The goal was to create a continuum of low-barrier services that met people wherever they were in their relationship with substance use.
In Portland, Measure 110 funding supported new drop-in centers in Old Town and East Portland, expanded mobile outreach teams, and funded additional beds at existing residential facilities. In the Willamette Valley, rural communities received resources for telehealth-based treatment and transportation assistance to get individuals to appointments. Statewide, hundreds of new peer support positions were created.
The rollout of funding was not without challenges. Delays in distributing grants meant that some programs did not begin operating until late 2022, nearly two years after the measure passed. Administrative requirements for the new BHRNs were complex, and some smaller organizations lacked the capacity to apply for or manage the funding effectively.
How Funds Were Allocated
The Drug Treatment and Recovery Services Fund distributed grants across four primary categories: treatment services, harm reduction, housing support, and peer-delivered services. Each county's BHRN was responsible for assessing local needs and distributing funds accordingly.
- Treatment services received the largest share, funding residential beds, outpatient slots, and MAT expansion.
- Harm reduction funding supported naloxone distribution, syringe services, and drug checking programs.
- Housing grants provided sober living subsidies, transitional housing, and rapid rehousing for individuals leaving treatment.
- Peer support funding created new positions and expanded training programs for certified recovery mentors.
The Citation and Hotline System
Under Measure 110, individuals found in possession of small amounts of drugs received a citation rather than an arrest. The citation included a phone number for the Lines for Life treatment hotline, and calling the number to complete a health screening would result in dismissal of the $100 fine. The system was designed to be the bridge between decriminalization and treatment entry.
In practice, the citation-to-hotline pathway was used far less frequently than proponents had anticipated. Data from the first two years showed that fewer than 1% of individuals who received citations called the hotline. Many individuals simply discarded the citation, and enforcement of the $100 fine was inconsistent across jurisdictions. The low engagement rate became one of the most cited criticisms of the measure.
Defenders of the system argued that measuring success solely by hotline call volume missed the broader picture. They pointed to increases in voluntary treatment admissions, expanded harm reduction contacts, and the reduction in criminal records for drug possession as meaningful outcomes independent of the citation system.
Low utilization of the citation-to-treatment pathway does not diminish the effectiveness of evidence-based treatment itself. If you need help, call Trust SoCal at (949) 280-8360 or reach out to any licensed treatment provider.
Overdose Deaths and Public Health Data
The most troubling data point in the Measure 110 debate is the trajectory of overdose deaths. Oregon's drug overdose fatalities rose from 472 in 2019 to over 1,000 in 2023, with fentanyl accounting for the majority of the increase. Portland and Multnomah County experienced the sharpest increases, but the trend was statewide. These numbers placed Oregon among the states with the fastest-growing overdose death rates in the nation.
Attributing the overdose surge directly to Measure 110 is contested. The same period saw sharp increases in fentanyl deaths across nearly every U.S. state, regardless of drug policy. The national fentanyl supply expanded dramatically between 2020 and 2024, and the COVID-19 pandemic disrupted treatment access and social support networks everywhere. Researchers caution against isolating one policy variable in a multi-factorial crisis.
Nonetheless, the perception that decriminalization contributed to worsening outcomes was politically powerful. By 2024, public sentiment had shifted significantly, and the Oregon legislature took action to modify the measure's approach.
National Context for Oregon's Numbers
Between 2019 and 2023, national drug overdose deaths increased from approximately 71,000 to over 112,000. States with traditional criminal penalties for drug possession, including Texas, Tennessee, and West Virginia, experienced overdose increases on par with or exceeding Oregon's. This context does not exonerate any particular policy, but it does complicate claims that decriminalization alone drove Oregon's outcomes.
Legislative Amendments and the Path Forward
In March 2024, Oregon Governor Tina Kotek signed House Bill 4002, which effectively reversed key elements of Measure 110. The new law recriminalized public drug use, restored misdemeanor penalties for personal drug possession, and established deflection programs that route individuals toward treatment rather than incarceration when possible. The treatment funding mechanisms from Measure 110 were largely preserved.
The 2024 amendments reflected a bipartisan consensus that decriminalization without robust and rapid treatment access had not produced the intended results. The new framework attempts to combine accountability with treatment access, a hybrid approach that other states and cities are watching closely.
For individuals currently seeking treatment in Oregon, the policy shifts mean that the state's investment in treatment infrastructure remains intact even as the legal framework around drug possession has been tightened. The beds, clinics, peer support workers, and harm reduction services funded by Measure 110 continue to operate.
Regardless of policy changes, the need for addiction treatment has not diminished. If you or someone you know is struggling, call Trust SoCal at (949) 280-8360 for a confidential conversation about treatment options.
What Measure 110 Means for Treatment Seekers Today
The practical impact of Measure 110 and its subsequent amendments on someone seeking treatment in Oregon today is nuanced. The expanded treatment infrastructure, including more peer support, more outpatient slots, and more harm reduction services, is a direct and lasting benefit. Access to naloxone is more widespread, drug checking services can identify fentanyl contamination, and individuals can seek help without the same level of criminal justice fear that existed before 2021.
At the same time, the challenges that predated Measure 110 have not disappeared. Wait times for residential treatment remain significant, particularly for publicly funded programs. The workforce shortage in behavioral health continues to limit expansion. And for many individuals, the most effective treatment may involve leaving Oregon entirely for a residential program that provides geographic distance, specialized care, and a change of environment.
Trust SoCal has worked with numerous Oregon residents who decided that out-of-state treatment was the right choice for them. Our team helps with insurance verification, travel coordination, and aftercare planning that accounts for the return to Oregon communities. The policy environment in Oregon may shift, but the clinical principles of effective addiction treatment remain constant.
Evidence-Based Treatment Remains the Gold Standard
Policy debates about decriminalization, criminal penalties, and harm reduction are important, but they should not obscure a fundamental reality: evidence-based clinical treatment is the most effective intervention for substance use disorders. Medically supervised detoxification, behavioral therapies such as cognitive-behavioral therapy and motivational interviewing, medication-assisted treatment for opioid and alcohol use disorders, and sustained aftercare support have robust research backing spanning decades.
Whether an individual enters treatment voluntarily, through a deflection program, or through a court order, the clinical process is the same. Assessment, stabilization, therapeutic engagement, skills building, and transition planning form the core of effective treatment regardless of the policy context that brings someone through the door.
Recovery is possible regardless of how many times someone has tried before. Evidence-based treatment adapts to each individual's history and needs. Call (949) 280-8360 to learn about Trust SoCal's clinical approach.

Medical Review Board, MD, ABAM
Medical Director & Reviewer




